Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Downgrades NeuBase Therapeutics to Perform

Oppenheimer analyst Hartaj Singh downgrades NeuBase Therapeutics (NASDAQ:NBSE) from Outperform to Perform.
byBenzinga Newsdesk
October 21, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Oppenheimer analyst Hartaj Singh downgrades NeuBase Therapeutics (NASDAQ:NBSE) from Outperform to Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Bitcoin, Ethereum, Dogecoin Mixed As SEC Plans To Appeal XRP Ruling: Analyst Says Solana Could Replicate Cardano’s 2019 Bear Market Comeback

By Mehab Qureshi
August 9, 10:40 PM
Major cryptocurrencies experienced mixed trading on Wednesday evening as investors eagerly awaited the release of July's Consumer Price Index (CPI) in the United States. The CPI serves as a significant indicator of inflation and is set to be disclosed on Thursday.  

$DOGE